Logistic regression analysis to identify parameters to predict an outcome of BCVA >69 letters at months 12 and 24
Parameter | Estimate | OR | 95% CI | P value |
Month 12 | ||||
Intercept | −3.876 | |||
Treatment (0.5 mg vs control) | 1.240 | 11.951 | 7.044 to 20.275 | <0.0001 |
Lesion size (DA) | −0.168 | 0.845 | 0.770 to 0.928 | 0.0004 |
Age (years) | −0.036 | 0.965 | 0.938 to 0.992 | 0.0110 |
Baseline BCVA (letters) | 0.098 | 1.103 | 1.079 to 1.127 | <0.0001 |
Month 24 | ||||
Intercept | −3.111 | |||
Treatment (0.5 mg vs control) | 1.346 | 14.767 | 8.461 to 25.776 | <0.0001 |
Lesion size (DA) | −0.166 | 0.847 | 0.773 to 0.929 | 0.0004 |
Age (years) | −0.033 | 0.968 | 0.942 to 0.995 | 0.0189 |
Baseline BCVA (letters) | 0.079 | 1.082 | 1.061 to 1.103 | <0.0001 |
BCVA, best-corrected visual acuity; DA, disc area.